Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Anixa Biosciences Inc (ANIX)
|
Add to portfolio |
|
|
|
| Price: |
$3.06
| | Metrics |
| OS: |
30.9
|
M
| |
-48
|
% ROE
|
| Market cap: |
$94.6
|
M
| |
-82
|
% ROIC
|
|
Net cash:
|
$29.7
|
M
| |
$0.96
|
per share
|
|
EV:
|
$64.9
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($13.9)
|
M
| |
|
|
|
EBIT
|
($13.9)
|
M
| |
|
|
| EPS |
($0.45)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Oct-31-22 | Oct-31-21 | Oct-31-20 | Oct-31-19 | Oct-31-18 | Oct-31-17 | Oct-31-16 | Oct-31-15 |
| Revenues | 0.0 | 0.5 | 0.0 | 0.3 | 1.1 | 0.4 | 0.3 | 9.3 |
| Revenue growth | -100.0% | | -100.0% | -77.5% | 206.9% | 20.8% | -96.8% | 152.4% |
| Cost of goods sold | 0.0 | 0.4 | 0.1 | 0.2 | 1.7 | 0.1 | 0.2 | 3.6 |
| Gross profit | 0.0 | 0.1 | -0.1 | 0.1 | -0.6 | 0.3 | 0.1 | 5.6 |
| Gross margin | | 26.0% | | 33.5% | -50.7% | 71.2% | 27.5% | 60.6% |
| Selling, general and administrative | | | | | | 4.4 | 2.7 | 5.5 |
| Research and development | 6.7 | 6.2 | 4.4 | 5.5 | 6.8 | 1.6 | 1.6 | 0.7 |
| General and administrative | 7.2 | 7.1 | 5.6 | 5.7 | 6.9 | | | |
| EBITA | -13.9 | -13.1 | -10.3 | -11.1 | -14.3 | -5.8 | -4.2 | -0.6 |
| EBITA margin | | -2563.3% | | -4421.0% | -1284.4% | -1586.3% | -1394.6% | -6.7% |
| Amortization of intangibles | | | | 0.4 | | 0.3 | 0.3 | 0.3 |
| EBIT | -13.9 | -13.1 | -10.3 | -11.5 | -14.3 | -6.1 | -4.5 | -0.9 |
| EBIT margin | | -2563.3% | | -4588.5% | -1284.4% | -1676.0% | -1503.0% | -10.2% |
| Pre-tax income | -13.8 | -13.1 | -10.1 | -11.8 | -14.2 | -5.0 | -5.0 | -1.4 |
| Income taxes | -0.2 | -0.2 | -0.1 | -0.2 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 1.3% | 1.3% | 0.7% | 1.5% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -13.6 | -13.0 | -10.0 | -11.6 | -14.0 | -7.0 | -5.0 | -1.4 |
| Net margin | | -2530.1% | | -4658.8% | -1258.1% | -1935.9% | -1672.1% | -14.9% |
| |
| Diluted EPS | ($0.45) | ($0.45) | ($0.45) | ($0.59) | ($0.79) | ($0.58) | ($0.57) | ($0.16) |
| Shares outstanding (diluted) | 30.4 | 28.6 | 22.2 | 19.8 | 17.6 | 12.2 | 8.7 | 8.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|